| The association between factor XI deficiency and the risk of bleeding, cardiovascular, and venous thromboembolic events SS Moser, G Chodick, YG Ni, D Chalothorn, MD Wang, AR Shuldiner, ... Thrombosis and Haemostasis 122 (05), 808-817, 2022 | 24 | 2022 |
| Healthcare utilization and prevalence of symptoms in women with menopause: a real-world analysis S Sharman Moser, G Chodick, S Bar-On, V Shalev International journal of women's health, 445-454, 2020 | 22 | 2020 |
| Cost and consequences of nonadherence with oral bisphosphonate therapy: findings from a real-world data analysis S Sharman Moser, J Yu, I Goldshtein, S Ish-Shalom, V Rouach, V Shalev, ... Annals of Pharmacotherapy 50 (4), 262-269, 2016 | 20 | 2016 |
| Parity and the use of folic acid supplementation during pregnancy SS Moser, M Rabinovitch, R Rotem, G Koren, V Shalev, G Chodick BMJ Nutrition, Prevention & Health 2 (1), 30, 2019 | 19 | 2019 |
| Adherence with bisphosphonates and long-term risk of hip fractures: a nested case-control study using real-world data V Shalev, S Sharman Moser, I Goldshtein, J Yu, C Weil, S Ish-Shalom, ... Annals of Pharmacotherapy 51 (9), 757-767, 2017 | 11 | 2017 |
| Epidemiology of treatment resistant depression among major depressive disorder patients in Israel S Sharman Moser, G Chodick, S Gelerstein, N Barit Ben David, V Shalev, ... BMC psychiatry 22 (1), 541, 2022 | 8 | 2022 |
| Association between diabetes mellitus and reduced efficacy of pembrolizumab in non–small cell lung cancer Y Leshem, Y Dolev, N Siegelmann‐Danieli, S Sharman Moser, L Apter, ... Cancer 129 (18), 2789-2797, 2023 | 6 | 2023 |
| Cancer‐associated venous thromboembolism in Israel: Incidence, risk factors, treatment, and health care utilization in a population based cohort study S Sharman Moser, G Spectre, P Raanani, O Friedman‐Mazursky, ... Research and Practice in Thrombosis and Haemostasis 6 (4), e12653, 2022 | 3 | 2022 |
| The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer S Sharman Moser, F Tanser, N Siegelmann-Danieli, L Apter, G Chodick, ... Journal of Pharmaceutical Policy and Practice 16 (1), 22, 2023 | 2 | 2023 |
| Cancer‐associated venous thromboembolism in Israel: Incidence, risk factors, treatment, and health care utilization in a population based cohort study SS Moser, G Spectre, P Raanani, O Friedman‐Mazursky, M Tirosh, ... Research and Practice in Thrombosis and Haemostasis 6 (4), e12653, 2022 | 1 | 2022 |
| Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting S Sharman Moser, L Apter, I Livnat, R Ginsburg, A Yarden, M Drori, ... Breast Cancer: Targets and Therapy, 105-116, 2024 | | 2024 |
| Real world clinical outcomes of patients with HER2 positive metastatic breast cancer with central nervous system involvement treated with modern regimens. N Siegelmann-Danieli, I Livnat, R Ginsburg, A Yarden, L Apter, M Drori, ... Journal of Clinical Oncology 41 (16_suppl), e13040-e13040, 2023 | | 2023 |
| Bisphosphonate non-adherence a common, costly issue S Sharman Moser PharmacoEconomics & Outcomes News 745, 11-30, 2016 | | 2016 |
